Literature DB >> 29790176

Tau filaments in neurodegenerative diseases.

Michel Goedert1.   

Abstract

The ordered assembly of Tau protein into abnormal filamentous inclusions is a defining characteristic of many human neurodegenerative diseases. Thirty years ago, we reported that Tau is an integral component of the intraneuronal filaments of Alzheimer's disease. All six brain Tau isoforms make up those filaments. Twenty years ago, we and others showed that mutations in MAPT, the Tau gene, cause familial forms of frontotemporal dementia, thus proving that dysfunction of Tau protein is sufficient to cause neurodegeneration and dementia. More recently, we showed that high-resolution structures of Tau filaments from human brain can be determined by electron cryo-microscopy. These filaments may form the seeds that underlie the prion-like properties of aggregated tau.
© 2018 Federation of European Biochemical Societies.

Entities:  

Keywords:  Tau isoforms; Tau protein; molecular conformers; ordered assembly

Mesh:

Substances:

Year:  2018        PMID: 29790176     DOI: 10.1002/1873-3468.13108

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  35 in total

Review 1.  Application of yeast to studying amyloid and prion diseases.

Authors:  Yury O Chernoff; Anastasia V Grizel; Aleksandr A Rubel; Andrew A Zelinsky; Pavithra Chandramowlishwaran; Tatiana A Chernova
Journal:  Adv Genet       Date:  2020-05-04       Impact factor: 1.944

2.  Structural characterization of monoclonal antibodies targeting C-terminal Ser404 region of phosphorylated tau protein.

Authors:  Jessica E Chukwu; Erin E Congdon; Einar M Sigurdsson; Xiang-Peng Kong
Journal:  MAbs       Date:  2019-02-26       Impact factor: 5.857

3.  Tau repeat regions contain conserved histidine residues that modulate microtubule-binding in response to changes in pH.

Authors:  Rabab A Charafeddine; Wilian A Cortopassi; Parnian Lak; Ruensern Tan; Richard J McKenney; Matthew P Jacobson; Diane L Barber; Torsten Wittmann
Journal:  J Biol Chem       Date:  2019-04-16       Impact factor: 5.157

4.  Distinct populations of highly potent TAU seed conformers in rapidly progressing Alzheimer's disease.

Authors:  Chae Kim; Tracy Haldiman; Sang-Gyun Kang; Lenka Hromadkova; Zhuang Zhuang Han; Wei Chen; Frances Lissemore; Alan Lerner; Rohan de Silva; Mark L Cohen; David Westaway; Jiri G Safar
Journal:  Sci Transl Med       Date:  2022-01-05       Impact factor: 19.319

Review 5.  Tau and MAPT genetics in tauopathies and synucleinopathies.

Authors:  Etienne Leveille; Owen A Ross; Ziv Gan-Or
Journal:  Parkinsonism Relat Disord       Date:  2021-09-14       Impact factor: 4.402

Review 6.  Enzymatic Noncovalent Synthesis.

Authors:  Hongjian He; Weiyi Tan; Jiaqi Guo; Meihui Yi; Adrianna N Shy; Bing Xu
Journal:  Chem Rev       Date:  2020-08-19       Impact factor: 60.622

Review 7.  Regulation of Neurodegeneration-associated Protein Fragments by the N-degron Pathways.

Authors:  Mohamed A Eldeeb; Mohamed A Ragheb; Marwa H Soliman; Richard P Fahlman
Journal:  Neurotox Res       Date:  2022-01-18       Impact factor: 3.911

8.  A novel tau-based rhesus monkey model of Alzheimer's pathogenesis.

Authors:  Danielle Beckman; Paramita Chakrabarty; Sean Ott; Amanda Dao; Eric Zhou; William G Janssen; Kristine Donis-Cox; Scott Muller; Jeffrey H Kordower; John H Morrison
Journal:  Alzheimers Dement       Date:  2021-03-18       Impact factor: 21.566

Review 9.  Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Jared S Katzeff; Fiona Bright; Katherine Phan; Jillian J Kril; Lars M Ittner; Michael Kassiou; John R Hodges; Olivier Piguet; Matthew C Kiernan; Glenda M Halliday; Woojin Scott Kim
Journal:  Brain       Date:  2022-06-03       Impact factor: 15.255

10.  A multicenter comparison of [18F]flortaucipir, [18F]RO948, and [18F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis.

Authors:  Antoine Leuzy; Tharick A Pascoal; Olof Strandberg; Philip Insel; Ruben Smith; Niklas Mattsson-Carlgren; Andréa L Benedet; Hannah Cho; Chul H Lyoo; Renaud La Joie; Gil D Rabinovici; Rik Ossenkoppele; Pedro Rosa-Neto; Oskar Hansson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-05-27       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.